Outras notícias

Revisão sistemática atualizada e metanálise de estudos clínicos e pré-clínicos | Efeito poupador de opioides dos canabinoides para analgesia.

19 Jun, 2022 | 13:49h

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies – Neuropsychopharmacology

 

Comentário no Twitter

MA of RCTs: In patients with cancer pain no effect of cannabinoid administration on opioid dose was found (MD= −3.8 mg; −10.97 to 3.37) or % change in pain scores (MD=1.84; −2.05 to 5.72) https://t.co/tTckc0z8Oz pic.twitter.com/Gh7LvYRz0n

— PfOL (@psychopharmacol) May 20, 2022

 

---

Diretrizes para o tratamento de hipertensão.

19 Jun, 2022 | 13:29h

2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension – Acta Cardiologica Sinica

---

Diretriz de posicionamento | Tratamento da doença renal diabética.

19 Jun, 2022 | 13:28h

The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD – Diabetology & Metabolic Syndrome

---

Diretriz ESMO | Diagnóstico, tratamento e seguimento do câncer endometrial.

19 Jun, 2022 | 13:27h

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

---

Diretriz OMS | Caminhar e pedalar: evidências mais recentes que suportam a elaboração de políticas e práticas.

19 Jun, 2022 | 13:25h

Walking and cycling: latest evidence to support policy-making and practice – World Health Organization

 

Comentário no Twitter

Evidence shows that investments in promoting safe cycling and walking can play a key role in shaping health and mitigating climate change and improving the environment, says new WHO report 👉 https://t.co/KJetzwqojl#ECEH #THEPEP pic.twitter.com/HdS7VEfr32

— WHO/Europe (@WHO_Europe) June 6, 2022

 

---

Breve revisão | Como manejar a anticoagulação nos pacientes em oxigenação extracorpórea por membrana (ECMO).

19 Jun, 2022 | 13:24h

How to manage anticoagulation during extracorporeal membrane oxygenation – Intensive Care Medicine (se o acesso a este link for pago, tente este)

Conteúdo relacionado: 2021 ELSO Adult and Pediatric Anticoagulation Guidelines – ASAIO Journal

---

Breve revisão | Morbidade de saúde mental, autolesão e suicídio em sobreviventes e cuidadores de UTI.

19 Jun, 2022 | 13:22h

Mental health morbidity, self-harm, and suicide in ICU survivors and caregivers – Intensive Care Medicine (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

#ICU mental health outcomes? The more we discover, the more we realize we need to care for a vulnerable population!
🧠 mental health morbidity among survivors
🧠 mental health morbidity among caregivers
🧠 risk prediction/mitigation
🧠 future directions
🖇 https://t.co/wo8QdP8Mz9 pic.twitter.com/9jX6h9SdRz

— Intensive Care Medicine (@yourICM) June 7, 2022

 

---

Canadá exigirá que um alerta seja impresso em todos os cigarros.

19 Jun, 2022 | 13:20h

Canada to require a warning be printed on every cigarette – Associated Press

---

Análise de subgrupo em estudos clínicos randomizados: valores e limitações.

19 Jun, 2022 | 13:19h

Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

---

Estudo randomizado | Ustequinumabe vs. adalimumabe para terapia de indução e de manutenção em pacientes virgens de biológicos com doença de Crohn ativa moderada a grave.

19 Jun, 2022 | 13:18h

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn’s disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial – The Lancet (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

New @TheLancet – Sands et al – Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease (SEAVUE trial)https://t.co/Ov9ahRTQuC#IBD #GITwitter #Crohnsdisease pic.twitter.com/5f3vI6rRKd

— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) June 10, 2022

 

---